Other
Neoplasm by Special Category
CI-CAN-00000004Explore in graph →
Non-malignant21,349 active trials259 approved drugs3,859 evidence items
- NCIt
- C7062
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000004Explore in graph →
Clinical trials
95,726 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07121478 | Patients With High-grade Pancreatic Neuroendocrine Tumors | enrolling by invitation | Phase 2 | 46 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 1, 2025 | clinicaltrials |
| NCT06674538 | Clinical Trial to Treat Stage IV Cancer Patients | enrolling by invitation | Phase 1 | 12 | Moonshot AntibodiesINDUSTRY | 1 | Sep 22, 2025 | clinicaltrials |
| NCT07176455 |
| Temporal Transformation Mechanism and Intervention Strategies of Frail-related Dietary Behaviors in Older Gastric Cancer Survivors |
| enrolling by invitation |
| — |
| 438 |
| Nanjing Medical UniversityOTHER |
| 1 |
| Sep 22, 2025 |
| clinicaltrials |
| NCT06882876 | JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study | enrolling by invitation | Phase 1 | 20 | Xiangya Hospital of Central South UniversityOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT06942286 | Primary HPV Self-Collection in Indonesia | enrolling by invitation | N/A | 8,000 | Dharmais National Cancer Center HospitalOTHER_GOV | 1 | Sep 17, 2025 | clinicaltrials |
| NCT05893654 | Melphalan Chemoreduction for Ocular Melanoma(MELCOM) | enrolling by invitation | Phase 1 / Phase 2 | 10 | Hospital das Clínicas de Ribeirão PretoOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT07171515 | Development & Clinical Application of K-PaC Registry Version 2.0 | enrolling by invitation | — | 6,923 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 12, 2025 | clinicaltrials |
| NCT05739071 | JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer | enrolling by invitation | N/A | 100 | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT06931860 | Head to Head Trial of Mailed Cologuard to Mailed FIT | enrolling by invitation | N/A | 400 | University of California, San DiegoOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT07155616 | NON-INVASIVE BLOOD FLOW ASSESSMENT: Computational Tool for Measuring Arterial Flow From CT(NOVELLA) | enrolling by invitation | — | 100 | Hospital Clinic of BarcelonaOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT01460264 | An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study(BIG3) | enrolling by invitation | — | 10,000 | Region SkaneOTHER | 1 | Aug 29, 2025 | clinicaltrials |
| NCT07129005 | Radiomics-Based Non-Invasive MRI Differentiation of Uterine Sarcomas and Fibroids | enrolling by invitation | — | 520 | Tongji HospitalOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT07130149 | Sonodynamic-Chemoradiotherapy Integration in Glioblastoma | enrolling by invitation | Phase 2 | 230 | Yingjuan ZhengOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT05385861 | Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET | enrolling by invitation | Phase 1 / Phase 2 | 52 | National Health Research Institutes, TaiwanOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT06424275 | Prostate Cancer Awareness and Initiative for Screening in the European Union(PRAISE-U) | enrolling by invitation | — | 20,000 | European Association of Urology Research FoundationOTHER | 4 | Aug 15, 2025 | clinicaltrials |
| NCT06941818 | HS-IT101 Injection in the Treatment of Advanced Melanoma | enrolling by invitation | Phase 1 | 10 | Qingdao Sino-Cell Biomedicine Co., Ltd.INDUSTRY | 1 | Aug 14, 2025 | clinicaltrials |
| NCT07101900 | 68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses | enrolling by invitation | Phase 2 | 100 | Peking Union Medical College HospitalOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT05913999 | Serial PET MPI in Patients Undergoing Cancer Treatment | enrolling by invitation | — | 60 | University of California, Los AngelesOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT07107815 | A Study On The Prediction of Neoadjuvant Efficacy For Rectal Cancer Based On MR Cytometry Imaging and Deep-radiomics | enrolling by invitation | — | 250 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT07091565 | Supporting Sexual Recovery in Women With Bladder Cancer(SPARC) | enrolling by invitation | — | 60 | King's College LondonOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT07072676 | The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.(Risk of fall) | enrolling by invitation | N/A | 30 | LMU KlinikumOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT06391749 | Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)(K-ACCELERATE) | enrolling by invitation | — | 1,000 | Gene SolutionsINDUSTRY | 1 | Jul 16, 2025 | clinicaltrials |
| NCT07060625 | The Effect of Semi-recumbent Position on Hypoxemia After Lung Segment/Lobe Surgery | enrolling by invitation | — | 308 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT07058753 | Prehabilitation in Ovarian Cancer Patients During Chemiotherapy Before Cytoreductive Surgery.(PREHONED) | enrolling by invitation | N/A | 100 | Medical University of SilesiaOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT07056205 | Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer. | enrolling by invitation | — | 100 | Sohag UniversityOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT07053904 | Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors | enrolling by invitation | Phase 1 | 54 | PharmaEssentiaINDUSTRY | 1 | Jul 8, 2025 | clinicaltrials |
| NCT07051265 | Effect of Transcutaneous Electrical Nerve Stimulation or Acupressure on Pain in Patients With Head and Neck Cancer | enrolling by invitation | N/A | 240 | Kaohsiung Veterans General Hospital.OTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT07052448 | The Efficacy of Sequential RT After Triple Therapy for uHCC | enrolling by invitation | — | 35 | Fujian Provincial HospitalOTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT07046832 | Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy | enrolling by invitation | N/A | 104 | MediView XR, Inc.INDUSTRY | 1 | Jul 2, 2025 | clinicaltrials |
| NCT07047937 | Explainable Machine Learning for Predicting Early Gastric Cancer | enrolling by invitation | — | 10 | Wenzhou Central HospitalOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT06472765 | Vaginal Ecosystem and Network in the United States Study(VENUS) | enrolling by invitation | — | 3,250 | Vaginal Biome ScienceOTHER | 2 | Jul 1, 2025 | clinicaltrials |
| NCT07042841 | AI-Driven Quantitative Decision and Surgical Planning System for Liver Cancer | enrolling by invitation | — | 300 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT07041229 | Comparison of Methods for Removing Large Benign Broad-based Epithelial Neoplasms of the Colon: ESD and EMR.(ESDEMR) | enrolling by invitation | N/A | 110 | Pirogov Russian National Research Medical UniversityOTHER | 1 | Jun 27, 2025 | clinicaltrials |
| NCT06896110 | Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma | enrolling by invitation | Phase 1 | 34 | Andrew P. GrovesOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT07034859 | Cabergoline in the Management of Nonfunctioning Pituitary Adenoma | enrolling by invitation | Phase 4 | 30 | National Taiwan University HospitalOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT07023848 | PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors | enrolling by invitation | Early Phase 1 | 10 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT07023861 | The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies | enrolling by invitation | Early Phase 1 | 20 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT07023068 | ⁶⁸Ga-DPA in the Lung Cancer Diagnosis | enrolling by invitation | Early Phase 1 | 40 | Peking Union Medical College HospitalOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT07016737 | Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy(ESO-Nanjing12) | enrolling by invitation | Phase 3 | 79 | Ye jinjunOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT06276140 | Iron-deficiency Anaemia and Its Impact on Recovery After Colorectal Cancer Surgery(ID-COLO) | enrolling by invitation | — | 200 | Oncology Institute of VojvodinaOTHER_GOV | 1 | Jun 4, 2025 | clinicaltrials |
| NCT06999148 | Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis | enrolling by invitation | Phase 2 | 216 | Yingjuan ZhengOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT03031249 | Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia | enrolling by invitation | Phase 1 / Phase 2 | 80 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT06997458 | Liquid BiOpsy, Lung and Colon Cancer in AndaluciA(LOLA-PROJECT) | enrolling by invitation | — | 500 | Fundación Pública Andaluza para la Investigación Biomédica Andalucía OrientalOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT04165460 | Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients | enrolling by invitation | N/A | 92 | National Institute of CancerologíaOTHER_GOV | 1 | May 28, 2025 | clinicaltrials |
| NCT06992687 | A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors | enrolling by invitation | Phase 1 / Phase 2 | 30 | Shanghai Huaota Biopharmaceutical Co., Ltd.INDUSTRY | 1 | May 28, 2025 | clinicaltrials |
| NCT06990178 | Adaptive Neoadjuvant Therapy for Esophageal Cancer | enrolling by invitation | N/A | 43 | Cancer Hospital Chinese Academy of Medical Science, Shenzhen CenterOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT06984055 | Diagnostic Accuracy of Endocytoscopy for Superficial Esophageal Neoplasia | enrolling by invitation | — | 600 | Changhai HospitalOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT06419179 | Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)(GUIDANCE) | enrolling by invitation | Phase 2 | 29 | University of CologneOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT06967662 | Selective Plasma Adsorption of Extracellular DNA in Prevention of Intraoperative Metastasis in Pancreatic Cancer (Pilot Study)(INTRACOR_pilot) | enrolling by invitation | N/A | 28 | Ilyinskaya Hospital, JSCOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT06703944 | Risk Model for Metastasis Detection of Neuroblastoma(NB) | enrolling by invitation | — | 500 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 15, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Oct 1, 2025source: clinicaltrials